Aurora Cannabis | ACB
Stock Price
6.05
Daily Change
0.03 0.50%
Monthly
-25.86%
Yearly
-3.97%
Q4 Forecast
8.37


Peers Price Chg Day Year Date
ANI Pharmaceuticals 56.91 1.05 1.88% 9.76% Nov/22
British American Tobacco 2,969.00 46.00 1.57% 16.14% Nov/22
Cronos Group 2.90 0.06 2.11% 6.23% Nov/22
Knight Therapeutics 5.29 -0.01 -0.19% 0.57% Nov/22
Imperial Brands 2,532.00 23.00 0.92% 38.10% Nov/22
Altria 56.75 0.79 1.41% 36.85% Nov/22
Organigram Holdings 2.15 0.05 2.14% 25.73% Nov/22
Philip Morris International 129.99 -1.21 -0.92% 37.79% Nov/22
Boston Beer 312.80 5.62 1.83% -8.36% Nov/22
Constellation Brands 239.62 -1.15 -0.48% 0.52% Nov/22
Molson Coors Brewing 60.41 -0.01 -0.01% 0.70% Nov/22
Tilray 1.88 0.04 2.17% -22.63% Nov/22
Canopy Growth 5.48 0.07 1.29% -29.74% Nov/22

Indexes Price Day Year Date
TSX 25444 53.60 0.21% 26.48% Nov/22

Aurora Cannabis Inc traded at 6.05 this Friday November 22nd, increasing 0.03 or 0.50 percent since the previous trading session. Looking back, over the last four weeks, Aurora Cannabis gained 25.86 percent. Over the last 12 months, its price fell by 3.97 percent. Looking ahead, we forecast Aurora Cannabis Inc to be priced at 8.37 by the end of this quarter and at 8.11 in one year, according to Trading Economics global macro models projections and analysts expectations.

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis derivative products in Canada and internationally. Its segments include Canadian Cannabis, International Cannabis and Bevo. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. It produces approximately 150,000 kilograms (kg) of cannabis biomass annually.